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PreviewsGiven the pro-B cell-specific and Pax5
dependency of the PAIR sequence, as
measured by transcriptional activity and
pro-B cell preferential binding of CTCF
and cohesin to these same sequences,
coupled with known functional require-
ment of Pax5 in distal VH recombination,
Ebert et al. (2011) propose that PAIRs
may represent the long sought cis-regula-
tory elements critical for Igh looping to
ensure utilization of distal VHs in VHDJH
rearrangements. In the context of such
a model, Pax5 might activate PAIRs,
perhaps via antisense transcription, allow-
ingPAIRs to form the baseof rosette loops
that bring distal VHs into V(D)J recombina-
tion complexwith the DJH, iEm, and poten-
tially other elements via CBEs in the VH to
DH intergenic region and/or in the region
downstream of the CHs. Testing of such
models will require deleting these pro-
posed regulatory elements and mutating
factor binding sites within them to test
effects on V(D)J recombination. As noted
by Ebert et al. (2011), this will be chal-
lenging given the repetitive nature of the
VH locus as well as potential redundancy.
It may also be further complicated if therearemany different VH loops formed across
the Igh locus, with only one or a few in a
givenprogenitor B cell. Suchexperimental
difficulties might require, if possible, trun-
cating the VH portion of Igh. Another very
important experiment will be to mutate
the more unique potential looping ele-
ments (e.g., CBEs) in the downstream
portions of Igh to test effects on distal VH
gene utilization. Finally, given that the
large human IGH must also have mecha-
nisms to ensure utilization of distal versus
proximal VHs, it will be important to deter-
mine whether PAIR-related sequence
exist in the human.
Overall, the finding of the PAIR
sequences in the upstream portion of
the Igh locus provides an important focus
for future studies aimed at solving the
long-standing mystery of how the Igh
locus organizes itself during V(D)J recom-
bination to ensure broad VH utilization and
a diverse antibody repertoire.REFERENCES
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A new report in Immunity shows that, rather than driving themetabolic changes required for proliferation, Akt
controls the gene expression programs that determine whether activated CD8+ T cells differentiate into
memory or effector cells.The multifunctional cytokine interleukin-2
(IL-2) can drive metabolic changes
needed to insure that activated CD8+
T cells can rapidly expand in response to
infection as well as develop the effector
functions needed to eradicate the threat
posed by infected host cells. Additionally,
the capacity to produce IL-2 is a central
feature of the long-lived memory popula-
tion that persist following contraction ofthe effectors. A key goal for immunolo-
gists has therefore been to identify the
pathways and players through which
signals emanating from a single cytokine
receptor can lead to the downstream
gene expression events required to coor-
dinate the metabolic and differentiation
needs of an expanding clone. An impor-
tant early ‘‘branch point’’ for this division
of labor is thought to occur with the IL-2-mediated generation of the lipid second
messenger phosphatidylinositol 3,4,5-tri-
sphosphate (PI(3,4,5)P3), the product of
phosphatidylinositol 3-kinases (PI3K).
This phosporylated lipid recruits the spe-
cific signaling intermediates via special-
ized lipid-binding pleckstrin homology
(PH) domains and itself becomes acti-
vated to initiate further signaling cas-
cades. Two key players in this processFebruary 25, 2011 ª2011 Elsevier Inc. 141
Immunity
Previewsare Akt (protein kinase B, PKB) and PDK1
(3-phosphoinositide-dependent protein
kinase 1), both which can be recruited to
the plasma membrane by PI(3,4,5)P3)
and activate downstream kinases. In the
case of PDK1, Akt itself is a substrate for
PDK1-dependent activation via phos-
phorylation at its T308 site. Akt has tradi-
tionally been associated with metabolic
pathways in T cells, based mostly on
studies in which it was targeted to the
membrane by myristoylation and mani-
fested a corresponding effect on growth
and survival of proliferating thymocytes
(Juntilla and Koretzky, 2008). A similar
role in mature T cells was suggested by
studies using constitutively active Akt
that could induce growth and survival of
CD4+, but remarkably not CD8+, T cells,
raising the possibility that these subsets
are wired differently with respect to the
downstream consequences of activating
the PI3K-Akt pathway (Finlay and Can-
trell, 2010).
In this issue of Immunity, Macintyre
et al. (2011) reveal that, in contrast to
controlling metabolism in CD8+ T cells,
Akt has a direct role in regulating whether
their differentiation leads them to either
the memory or effector fate. To investi-
gate the role of Akt in CD8+ T cells, Mac-
intyre et al. used an in vitro model in which
T cell receptor (TCR)-stimulated cells are
cultured in IL-2 in order to sustain the
signals that lead effector cell generation
(Manjunath et al., 2001). Using either
pharmacologic or genetic inhibition of
the p110d subunit of PI3K that activates
Akt or an allosteric inhibitor of all 3 Akt
isoforms, Macintyre et al. found that, in
the absence of Akt function, TCR-stimu-
lated CD8+ T cells could both proliferate
and survive in response to IL-2. Sub-
sequent studies using a genetically tar-
geted model showed that IL-2-driven
proliferation is actually mediated by
PDK1, not Akt, as deletion of PDK1 in
CD8+ T cells rendered them unable to
proliferate or sustain glucose uptake in
response to IL-2. Remarkably, although
the PDK1-deficient CD8+ T cells failed to
divide in response to IL-2, they did not
die, suggesting that survival is mediated
by yet another distinct pathway. These
findings reveal that Akt controls neither
IL-2-mediated proliferation nor glucose
uptake in this system and raised ques-
tions as to its actual function in enabling
the CD8+ T cell response. To further142 Immunity 34, February 25, 2011 ª2011 Eexplore this, Macintyre et al. performed
microarray analysis to profile gene-
expression patterns from Akt-inhibited
and PDK1 null CD8+ T cells. In support
of their biological data, they found that
genes encoding proteins involved in
glucose uptake and lipid metabolism
were overrepresented among genes
regulated by PDK1 independent of Akt.
Surprisingly, the Akt-inhibited CD8+
T cells induced genes that are important
for memory function in CD8+ T cells.
These include cytokine receptors that
are important for their homeostatic sur-
vival (IL-7R), as well as the chemokine
receptors (CCR7) and adhesion mole-
cules (CD62L/L-selectin) that direct
migration of T cells to lymph nodes and
retain them there.
The ‘‘memory-like’’ transcriptional pro-
file was subsequently confirmed at the
level of CD8+ T cell function in vivo by
showing that inhibition of Akt or PI3K
p110d changed the differentiation fate of
CD8+ T cells that were originally destined
to become effectors, in effect ‘‘reprog-
ramming’’ them to become memory
phenotype cells by restoring the expres-
sion of CCR7 and CD62L and thereby
enabling these cells to home to secondary
lymphoid organs in adoptive transfer
experiments just as bona fide memory
cells would be expected to do. Concomi-
tant with induction of genes related to
memory function, Macintyre et al. also
show that Akt inhibition caused a de-
crease in the expression of genes encod-
ing molecules critical to CD8+ T cell
effector function, including Interferon
gamma (IFN-g), Fas ligand (FasL), several
of the granzymes, as well as perforin. The
picture emerging from these findings is
that IL-2-driven Akt activation simulta-
neously coordinates a program of gene
expression related to the development of
effector functions while repressing genes
involved in determining the memory
phenotype, a far cry from its expected
role in control of metabolism. Macintyre
et al. delved further into the underlying
mechanism and found that a common
feature of the Akt-responsive genes is
their regulation by the Foxo transcription
factors, mammalian orthologs of the
‘‘Forkhead box’’ factors first identified in
Caenorhabditis elegans in programming
resistance to oxidative stress (Burgering,
2008). Foxo factors have been shown to
control highly specialized programs oflsevier Inc.gene expression in the adaptive immune
response of mammals through both
transactivation and repression, including
those involved in the differentiation,
survival, and metabolism of lymphocytes
(Hedrick, 2009). As with many transcrip-
tion factors, the activity of the Foxos is
regulated via their phosporylation-depen-
dent nuclear exclusion through binding to
cytoplasmic 14-3-3 proteins. Previously,
work in human T cells had established
that Akt phosphorylates and inactivates
key Foxo proteins in T cells through this
mechanism, and a more recent report
has shown that Foxo proteins can regu-
late expression of the same ‘‘memory
phenotype’’ molecules such as IL-7R,
CCR7, and L-selectin that Macintyre
et al. identified in their study in a process
that involves kruppel-like factor-2 (KLF2)
as a critical target gene for their induction
(Fabre et al., 2005; Kerdiles et al., 2009). In
an opposing role in regulating memory
genes, Macintyre et al. also found that
Foxo factors are responsible for the
capacity of Akt to maintain key effector
molecules with the demonstration that
a mutant form of Foxo3a lacking sites
required for phosphorylation by Akt pre-
vented CD8+ T cells from producing IFN-
g in response to TCR signaling.
The cumulative data in this and recent
allied reports suggest that the role of Akt
in guiding the fate of CD8+ T cells is one
of coordination of mutually exclusive pro-
grams of gene expression. Strong and/or
sustained Akt signals will favor the devel-
opment of effectors in TCR-stimulated
CD8+ T cells by promoting genes that
contribute to effector functions while re-
pressing those associated with memory.
The inhibition studies performed myMac-
intyre et al. suggest that when these
signals are weak, or perhaps antagonized
at various levels, the differentiation pro-
cess will lead to the generation of memory
cells capable of localizing secondary
lymphoid organs. Remarkably, both out-
comes appear to be controlled by a
common mechanism involving specific
members of the Foxo family of transcrip-
tion factors whose Akt-regulated pres-
ence within the nucleus can either induce
or repress the relevant target genes
(Figure 1). These findings shed new light
on a unique link established by a kinase
that likely found its original function in
the pan-cellular process of metabolism









































Figure 1. Akt-Dependent Regulation of Effector andMemory Cell-Associated Genes in CD8+
T Cells
IL-2 signals act through PI3K to generate PI(3,4,5)P3 and recruit PDK1 and Akt to the membrane where
they become activated by phosphorylation. Active PDK1 can then work through downstream members
of the AGC kinase family to provide for the metabolic needs of proliferation. PDK1 also phosphorylates
Akt, which can in turn phosphorylate and inactivate Foxo transcription factors on multiple residues and
facilitate binding to cytosolic 14-3-3 proteins, which prevents translocation into the nuclues. In the
nucleus, Foxo transcription factors can induce transcription of memory phenotype genes, including
Klf2 and its target genes involved in trafficking and homeostatic survival, whereas its exclusion from the
nucleus in stimulated CD8+ T cells results in repression of KLF-2 target genes and promotes expression
of genes associated with effector functions.
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Previewsprograms of genes expression that are
key to the functions of effector and
memory CD8+ T cells. The new perspec-
tive offered by the results of Macintyre
et al. were based in an in vitro experi-
mental system, however, which lacksmany of the additional signals found
under in vivo priming conditions that
could possibly counteract or modify the
TCR + IL-2 signals used to stimulate
CD8+ T cells in this report. As such, these
additional signals missing from the in vitroImmunity 34,system used by Macintyre et al. may play
a role in generating the range of functional
phenotypes that can emerge from a single
CD8+ T cell precursor primed in intact
animals by a complex pathogen (Stem-
berger et al., 2007). Accordingly, the func-
tional heterogeneity found in effector
versus memory phenotype cells may
turn out to reflect specific differences in
the content or activity of Foxo factors or
in the range of cofactors that modify their
range of target genes. In any case, these
new findings are certain to generate
much discussion in the field and give
new perspective to ongoing experiments
into the molecular regulation of immune
memory.REFERENCES
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